Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 January 2019 | Story Zama Feni | Photo Barend Nagel
Prof Matlabisa
Prof Motlalepula Matlabisa of the Department of Pharmacology.

Two South African government departments have granted the University of the Free State’s Department of Pharmacology a combined amount of R15 million for the establishment of four tea farms in the disadvantaged communities in the North West and Eastern Cape Communities.

The head of the project Prof Motlalepula Matsabisa at the Department of Pharmacology said that that Department of Environmental Affairs (DEA) has granted an amount of R10 million for the community research in the respective provinces.

This grant is a top up to the R5 million they received from the Department of Science and Technology for the “community implementation on indigenous health infusions or teas as commonly known.”

The DEA will in the near future sign a Memorandum of Agreement (MOA) with the university.


Tea project set to empower communities


“The project is to implement and build structures in the four communities we work with in the North West and Eastern Cape,” he said.

The identified areas for the project are in the Eastern Cape towns of Alice and Idutywa as well another two North West communities in Zeerust.

Prof Matsabisa indicated that the project will be a manifestation of “how science can contribute to economic growth, poverty alleviation and job creation.” 

“It was very interesting to have discovered that some French and German companies have already displayed interest in the projects,” he said.

He stated that a project of this nature is a good initiative by the UFS and it will also show that the university’s research activities are national. “We have been researching and developing indigenous teas which have now attracted interest locally and internationally by huge companies such as Nestle, Tiger Brands, Moringa World etc,” he said. 


Taking it slowly


At the initial stages of the tea farming project, Prof Matsabisa said they would start in small portions of utilising five hectares in each of the four projects and as the project gains momentum, they would expand.

Prof Matlabisa said that an environmental impact assessment has already been conducted and they were waiting for the DEA to give them a go ahead for the land preparations.



News Archive

Medical student stars in local movie
2015-10-15


Sung-Hoon as the on-screen character Operator 2

Sung-Hoon Kim’s dream of starring in a movie became a reality with the release of Reconnect on 16 October 2015 in Nu Metro cinemas across the country.

The second-year medical student at the University of the Free State transitioned into a professional actor in December 2013, when he made the leap from his high school drama stage to shooting for the big screen.

“I did plays in high school where I had roles like Simba in The Lion King,” said the first-time movie star. 

The film is a purely South African creation. It is set in Potchefstroom and Klerksdorp, Sung-Hoon’s former and current hometowns. Sung-Hoon plays two major roles: XJ-1- a robot, and the on-screen role of artificial intelligence Operator 2 at SKY CORP - an international intelligence company that protects top secret information from around the world.

Reconnect was directed by the late Marius Swanepoel, who Sung-Hoon described as “a great blessing to all those privileged enough to have known him.” The movie explores the relationship between human beings and artificial intelligence.

Eric Scott discovers XJ-1 at an abandoned warehouse, and transfers him to SKY CORP where he becomes destructive. Eric and his friend, Jason, are then faced with the challenge of containing the situation, and saving the company which XJ-1 has infected with a dangerous virus. As the science-fiction action unfolds, viewers catch a glimpse into the life of XJ-1.

Shooting the movie was an exciting experience for Sung-Hoon. “It was quite fun because I like imitating voices,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept